TBIO News and Press, Translate Bio Inc. From 09/28/23

SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® NGS Library Prep kit for Whole Genome Sequencing on the BioXp 3250 and BioXp 9600 systems ...

2023-08-29 16:19:04 ET More on Codex DNA BofA lowers rating on Telesis Bio to sector weight from overweight Telesis Bio gets $28 million in financing through preferred stock private placement Despite 22% gain today, Codex DNA still well down from June IPO price ...

SAN DIEGO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial Officer, effective August 28, 2023. As CFO, Kullback will be responsible for the Company's financial...

2023-08-11 16:02:08 ET Telesis Bio, Inc. (TBIO) Q2 2023 Earnings Conference Call August 10, 2023 04:30 p.m. ET Company Participants Todd Nelson - Founder, Chief Executive Officer Eric Esser - President, Chief Operating Officer Jen Carroll - Vice President of Inve...

2023-08-11 13:18:11 ET BofA  has lowered its rating of Telesis Bio ( NASDAQ: TBIO ) to sector weight from overweight, citing in part a slowdown in biopharma spending. "Facing a tepid biopharma spending environment, we see limited top-line visibility," the analysts wrote in ...

2023-08-11 09:58:47 ET Codex DNA press release ( NASDAQ: TBIO ): Q2 GAAP EPS of -$0.28 beats by $0.05 . Revenue of $8.65M (+51.8% Y/Y) beats by $1.25M . For further details see: Codex DNA GAAP EPS of -$0.28 beats by $0.05, revenue of $8.65M beats by $1.25M

SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the second quarter of 2023. “We achieved important milestones this quarter toward our path to profitabi...

SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its second quarter 2023 financial results on Thursday, August 10, 2023, after the market closes. In conjunction with ...

2023-07-07 17:04:10 ET Summary Investing Group leaders share lessons learned from their years of investing. Sector specific and general investing lessons are discussed. Participating contributors cover value, biotech, energy, commodities, and arbitrage. ~ Tim Murph...

2023-06-23 17:20:45 ET Summary Investing Groups leaders discuss one investing mistake they made and lessons learned from that mistake. Lessons learned from these mistakes include the importance of recognizing and adapting to changing market conditions, avoiding excessive leverage,...